Rare Diseases. National Institutes of Health. https://www.nih.gov/about-nih/nih-turning-discovery-into-health/promise-precision-medicine/rare-diseases. Accessed 3 Aug 2025.

The National Economic Burden of Rare Disease Study. EveryLife Foundation. https://everylifefoundation.org/burden-landing/. Accessed 3 Aug 2025.

Shen T, Lee A, Shen C, et al. The long tail and rare disease research: the impact of next-generation sequencing for rare Mendelian disorders. Genet Res (Camb). 2015;97:e15.

Article  Google Scholar 

Reinholdt L, Chesler E, Pera M, Rosenthal N. The rare-to-common disease journey: a winding road to new therapies. Trends Genet. 2025 Jun 2:S0168-9525(25)00110-6. https://doi.org/10.1016/j.tig.2025.05.003. Epub ahead of print. PMID: 40461388.

Xi Q, Jin S, Morris S. Economic evaluations of predictive genetic testing: A scoping review. PLoS One. 2023;18(8):e0276572. https://doi.org/10.1371/journal.pone.0276572. PMID: 37531363; PMCID: PMC10395838.

eClinicalMedicine. Raising the voice for rare diseases: under the spotlight for equity. EClinicalMedicine. 2023;57:101941. https://doi.org/10.1016/j.eclinm.2023.101941. PMID: 37064509; PMCID: PMC10102897.

Article  Google Scholar 

Newborn Screening in Your State. https://newbornscreening.hrsa.gov/your-state. Accessed 3 Aug 2025.

Yang L, Chen J, Shen B. Newborn Screening in the Era of Precision Medicine. Adv Exp Med Biol. 2017;1005:47–61. https://doi.org/10.1007/978-981-10-5717-5_3.

Baynam G, Hartman AL, Letinturier MCV, Bolz-Johnson M, Carrion P, Grady AC, Dong X, Dooms M, Dreyer L, Graessner H, Granados A, Groza T, Houwink E, Jamuar SS, Vasquez-Loarte T, Tumiene B, Wiafe SA, Bjornson-Pennell H, Groft S. Global health for rare diseases through primary care. Lancet Glob Health. 2024;12(7):e1192–9. https://doi.org/10.1016/S2214-109X(24)00134-7.

Article  Google Scholar 

Austin-Tse CA, Jobanputra V, Perry DL, Bick D, Taft RJ, Venner E, Gibbs RA, Young T, Barnett S, Belmont JW, Boczek N, Chowdhury S, Ellsworth KA, Guha S, Kulkarni S, Marcou C, Meng L, Murdock DR, Rehman AU, Spiteri E, Thomas-Wilson A, Kearney HM, Rehm HL. Medical genome Initiative*. Best practices for the interpretation and reporting of clinical whole genome sequencing. NPJ Genom Med. 2022;7(1):27. https://doi.org/10.1038/s41525-022-00295-z. PMID: 35395838; PMCID: PMC8993917.

Article  Google Scholar 

Scarano C, Veneruso I, De Simone RR, Di Bonito G, Secondino A, D’Argenio V. The Third-Generation sequencing challenge: novel insights for the omic sciences. Biomolecules. 2024;14(5):568. https://doi.org/10.3390/biom14050568. PMID: 38785975; PMCID: PMC11117673.

Article  Google Scholar 

Ali SS, Li Q, Agrawal PB. Implementation of multi-omics in diagnosis of pediatric rare diseases. Pediatr Res. 2025;97(4):1337–44. https://doi.org/10.1038/s41390-024-03728-w. Epub 2024 Nov 19. PMID: 39562738; PMCID: PMC12106075.

Article  Google Scholar 

Cooper DN, Krawczak M, Polychronakos C, Tyler-Smith C, Kehrer-Sawatzki H. Where genotype is not predictive of phenotype: towards an Understanding of the molecular basis of reduced penetrance in human inherited disease. Hum Genet. 2013;132(10):1077–130. https://doi.org/10.1007/s00439-013-1331-2. Epub 2013 Jul 3. PMID: 23820649; PMCID: PMC3778950.

Article  Google Scholar 

Payne JL, Wagner A. Latent phenotypes pervade gene regulatory circuits. BMC Syst Biol. 2014;8:64. https://doi.org/10.1186/1752-0509-8-64. PMID: 24884746; PMCID: PMC4061115.

Article  Google Scholar 

Rosina E, Pezzani L, Pezzoli L, Marchetti D, Bellini M, Pilotta A, Calabrese O, Nicastro E, Cirillo F, Cereda A, Scatigno A, Milani D, Iascone M. Atypical, Composite, or blended phenotypes: how different molecular mechanisms could associate in Double-Diagnosed patients. Genes (Basel). 2022;13(7):1275. https://doi.org/10.3390/genes13071275. PMID: 35886058; PMCID: PMC9319862.

Article  Google Scholar 

Crouch DJM, Bodmer WF. Polygenic inheritance, GWAS, polygenic risk scores, and the search for functional variants. Proc Natl Acad Sci U S A. 2020;117(32):18924–33. https://doi.org/10.1073/pnas.2005634117. Epub 2020 Aug 4. PMID: 32753378; PMCID: PMC7431089.

Article  Google Scholar 

Watanabe K, Stringer S, Frei O, Umićević Mirkov M, de Leeuw C, Polderman TJC, van der Sluis S, Andreassen OA, Neale BM, Posthuma D. A global overview of pleiotropy and genetic architecture in complex traits. Nat Genet. 2019;51(9):1339–1348. https://doi.org/10.1038/s41588-019-0481-0. Epub 2019 Aug 19. Erratum in: Nat Genet. 2020;52(3):353. doi: 10.1038/s41588-019-0571-z. PMID: 31427789.

Boyle EA, Li YI, Pritchard JK. An expanded view of complex traits: from polygenic to omnigenic. Cell. 2017;169(7):1177–86. https://doi.org/10.1016/j.cell.2017.05.038. PMID: 28622505; PMCID: PMC5536862.

Article  Google Scholar 

Liu C, Gershon ES. Endophenotype 2.0: updated definitions and criteria for endophenotypes of psychiatric disorders, incorporating new technologies and findings. Transl Psychiatry. 2024;14(1):502. https://doi.org/10.1038/s41398-024-03195-1. PMID: 39719446; PMCID: PMC11668880.

Article  Google Scholar 

Nava-Gonzalez EJ, Gallegos-Cabriales EC, Leal-Berumen I, Bastarrachea RA. Mini-Review: the contribution of intermediate phenotypes to GxE effects on disorders of body composition in the new OMICS era. Int J Environ Res Public Health. 2017;14(9):1079. https://doi.org/10.3390/ijerph14091079. PMID: 28926971; PMCID: PMC5615616.

Article  Google Scholar 

DeBoever C, Tanigawa Y, Aguirre M, McInnes G, Lavertu A, Rivas MA. Assessing digital phenotyping to enhance genetic studies of human diseases. Am J Hum Genet. 2020;106(5):611–22. https://doi.org/10.1016/j.ajhg.2020.03.007. Epub 2020 Apr 9. PMID: 32275883; PMCID: PMC7212271.

Article  Google Scholar 

Son JH, Xie G, Yuan C, Ena L, Li Z, Goldstein A, Huang L, Wang L, Shen F, Liu H, Mehl K, Groopman EE, Marasa M, Kiryluk K, Gharavi AG, Chung WK, Hripcsak G, Friedman C, Weng C, Wang K. Deep phenotyping on electronic health records facilitates genetic diagnosis by clinical exomes. Am J Hum Genet. 2018;103(1):58–73. Epub 2018 Jun 28. PMID: 29961570; PMCID: PMC6035281.

Article  Google Scholar 

McMurry J, Sizer A, Allaway R et al. Critical bottlenecks in rare disease research and care: a community perspective. https://zenodo.org/records/14907384. Accessed August 3, 2025.

Taruscio D, Gahl WA. Rare diseases: challenges and opportunities for research and public health. Nat Rev Dis Primers. 2024;10(1):13. https://doi.org/10.1038/s41572-024-00505-1.

Article  Google Scholar 

Ou P, Wen R, Shi L, Wang J, Liu C. Artificial intelligence empowering rare diseases: a bibliometric perspective over the last two decades. Orphanet J Rare Dis. 2024;19(1):345. https://doi.org/10.1186/s13023-024-03352-1. PMID: 39272071; PMCID: PMC11401438.

Article  Google Scholar 

Karako K. Artificial intelligence applications in rare and intractable diseases: Advances, challenges, and future directions. Intractable Rare Dis Res. 2025;14(2):88–92. https://doi.org/10.5582/irdr.2025.01030. PMID: 40485885; PMCID: PMC12143221.

Article  Google Scholar 

Nishat SMH, Shahid Tanweer A, Alshamsi B, Shaheen MH, Shahid Tanveer A, Nishat A, Alharbat Y, Alaboud A, Almazrouei M, Ali-Mohamed RA. Artificial intelligence: A new frontier in rare disease early diagnosis. Cureus. 2025;17(2):e79487. https://doi.org/10.7759/cureus.79487. PMID: 40135033; PMCID: PMC11933855.

Article  Google Scholar 

Gani I, Litchfield I, Shukla D, Delanerolle G, Cockburn N, Pathmanathan A. Understanding alert fatigue in primary care: qualitative systematic review of general practitioners attitudes and experiences of clinical alerts, Prompts, and reminders. J Med Internet Res. 2025;27:e62763. https://doi.org/10.2196/62763. PMID: 39918864; PMCID: PMC11845892.

Article  Google Scholar 

Grand View Research. Rare Disease Genetic Testing Market. (2025–2030). https://www.grandviewresearch.com/industry-analysis/rare-disease-genetic-testing-market. Accessed August 3, 2025.

Rare Diseases Treatment Market. (2025–2030). https://www.grandviewresearch.com/industry-analysis/rare-diseases-treatment-market-report. Accessed August 3, 2025.

Mikami K. Orphans in the market: the history of orphan drug policy. Soc Hist Med. 2019;32(3):609–30. https://doi.org/10.1093/shm/hkx098. Epub 2017 Nov 27. PMID: 31384102; PMCID: PMC6664588.

Article  Google Scholar 

Michaeli DT, Michaeli T, Albers S, Boch T, Michaeli JC. Special FDA designations for drug development: orphan, fast track, accelerated approval, priority review, and breakthrough therapy. Eur J Health Econ. 2024;25(6):979–97. https://doi.org/10.1007/s10198-023-01639-x. Epub 2023 Nov 14. PMID: 37962724; PMCID: PMC11283430.

Article  Google Scholar 

Fermaglich LJ, Miller KL. A comprehensive study of the rare diseases and conditions targeted by orphan drug designations and approvals over the Forty years of the orphan drug act. Orphanet J Rare Dis. 2023;18(1):163. https://doi.org/10.1186/s13023-023-02790-7. PMID: 37353796; PMCID: PMC10290406.

Article  Google Scholar 

Liu X, Liu H, Yang G, Jiang Z, Cui S, Zhang Z, Wang H, Tao L, Sun Y, Song Z, Hong T, Yang J, Gao T, Zhang J, Li X, Zhang J, Sang Y, Yang Z, Xue K, Wu S, Zhang P, Yang J, Song C, Wang G. A generalist medical Language model for disease diagnosis assistance. Nat Med. 2025;31(3):932–42. https://doi.org/10.1038/s41591-024-03416-6. Epub 2025 Jan 8. PMID: 39779927.

Article  Google Scholar 

Ao G, Chen M, Li J, Nie H, Zhang L, Chen Z. Comparative analysis of large Language models on rare disease identification. Orphanet J Rare Dis. 2025;20(1):150. https://doi.org/10.1186/s13023-025-03656-w. PMID: 40165285; PMCID: PMC11959745.

Article  Google Scholar 

Zhong W, Sun M, Yao S, Liu Y, Peng D, Liu Y, Yang K, Gao H, Yan H, Hao W, Yan Y, Yin C. Enhancing the accuracy of human phenotype ontology identification: comparative evaluation of multimodal large Language models. J Med Internet Res. 2025;27:e73233. https://doi.org/10.2196/73233. PMID: 40456109; PMCID: PMC12148245.

Article  Google Scholar 

Chimirri L, Caufield JH, Bridges Y, Matentzoglu N, Gargano M, Cazalla M, Chen S, Danis D, Dingemans AJM, Gehle K, Gehle P, Graefe ASL, Gu W, Ladewig MS, Lapunzina P, Nevado J, Niyonkuru E, Ogishima S, Seelow D, Tenorio Castaño JA, Turnovec M, de Vries BBA, Wang K, Wissink K, Yüksel Z, Zucca G, Haendel MA, Mungall CJ, Reese J, Robinson PN. Consistent performance of large Language models in rare disease diagnosis across ten Languages and 4917 cases. EBioMedicine. 2025;121:105957. https://doi.org/10.1016/j.ebiom.2025.105957. Epub 2025 Oct 14. PMID: 41092581; PMCID: PMC12552141.

Article  Google Scholar 

Zhang K, Zhou R, Adhikarla E, Yan Z, Liu Y, Yu J, Liu Z, Chen X, Davison BD, Ren H, Huang J, Chen C, Zhou Y, Fu S, Liu W, Liu T, Li X, Chen Y, He L, Zou J, Li Q, Liu H, Sun L. A generalist vision-language foundation model for diverse biomedical tasks. Nat Med. 2024;30(11):3129–41. https://doi.org/10.1038/s41591-024-03185-2. Epub 2024 Aug 7. PMID: 39112796.

Article  Google Scholar 

Ferber D, El Nahhas OSM, Wölflein G, Wiest IC, Clusmann J, Leßmann ME, Foersch S, Lammert J, Tschochohei M, Jäger D, Salto-Tellez M, Schultz N, Truhn D, Kather JN. Development and validation of an autonomous artificial intelligence agent for clinical decision-making in oncology. Nat Cancer. 2025;6(8):1337–49. https://doi.org/10.1038/s43018-025-00991-6. Epub 2025 Jun 6. PMID: 40481323; PMCID: PMC12380607.

Article  Google Scholar 

Ding T, Wagner SJ, Song AH, Chen RJ, Lu MY, Zhang A, Vaidya AJ, Jaume G, Shaban M, Kim A, Williamson DFK, Robertson H, Chen B, Almagro-Pérez C, Doucet P, Sahai S, Chen C, Chen CS, Komura D, Kawabe A, Ochi M, Sato S, Yokose T, Miyagi Y, Ishikawa S, Gerber G, Peng T, Le LP, Mahmood F. A multimodal whole-slide foundation model for pathology. Nat Med. 2025;31(11):3749–61. https://doi.org/10.1038/s41591-025-03982-3. Epub 2025 Nov 5. PMID: 41193692; PMCID: PMC12618242.

Article  Google Scholar 

Shi D, Zhang W, Yang J, Huang S, Chen X, Xu P, Jin K, Lin S, Wei J, Yusufu M, Liu S, Zhang Q, Ge Z, Xu X, He M. A multimodal visual-language foundation model for computational ophthalmology. NPJ Digit Med. 2025;8(1):381. https://doi.org/10.1038/s41746-025-01772-2. PMID: 40542189; PMCID: PMC12181238.

Article